Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Johnstone

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
European Heart Journal|February 21, 2008
Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine studySidney Chocron, Richard Baillot, Jean Lucien Rouleau, et al.
Circulation|December 12, 2007
Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgeryJean L Rouleau, Wayne J Warnica, Richard Baillot, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 4, 2011
Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic modelsKonstantin H Dragnev, Tian Ma, Jobin Cyrus, et al.
Molecular Cancer Therapeutics|May 21, 2013
Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancerTian Ma, Fabrizio Galimberti, Cherie P Erkmen, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
European Heart Journal|February 21, 2008
Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine studySidney Chocron, Richard Baillot, Jean Lucien Rouleau, et al.
Circulation|December 12, 2007
Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgeryJean L Rouleau, Wayne J Warnica, Richard Baillot, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 4, 2011
Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic modelsKonstantin H Dragnev, Tian Ma, Jobin Cyrus, et al.
Molecular Cancer Therapeutics|May 21, 2013
Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancerTian Ma, Fabrizio Galimberti, Cherie P Erkmen, et al.
Pageof 5